153 related articles for article (PubMed ID: 10338106)
1. The clinical safety of high-dose piracetam--its use in the treatment of acute stroke.
De Reuck J; Van Vleymen B
Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():33-7. PubMed ID: 10338106
[TBL] [Abstract][Full Text] [Related]
2. Piracetam in the treatment of acute stroke.
Orgogozo JM
Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():25-32. PubMed ID: 10338105
[TBL] [Abstract][Full Text] [Related]
3. The role of piracetam in the treatment of acute and chronic aphasia.
Huber W
Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():38-43. PubMed ID: 10338107
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.
De Deyn PP; Reuck JD; Deberdt W; Vlietinck R; Orgogozo JM
Stroke; 1997 Dec; 28(12):2347-52. PubMed ID: 9412612
[TBL] [Abstract][Full Text] [Related]
5. Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo.
Szalma I; Kiss A; Kardos L; Horváth G; Nyitrai E; Tordai Z; Csiba L
Ann Thorac Surg; 2006 Oct; 82(4):1430-5. PubMed ID: 16996947
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparin for the treatment of acute ischemic stroke.
Kay R; Wong KS; Yu YL; Chan YW; Tsoi TH; Ahuja AT; Chan FL; Fong KY; Law CB; Wong A
N Engl J Med; 1995 Dec; 333(24):1588-93. PubMed ID: 7477193
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
12. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
Diener HC; AlKhedr A; Busse O; Hacke W; Zingmark PH; Jonsson N; Basun H;
J Neurol; 2002 May; 249(5):561-8. PubMed ID: 12021946
[TBL] [Abstract][Full Text] [Related]
14. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study.
Bachert C; Chuchalin AG; Eisebitt R; Netayzhenko VZ; Voelker M
Clin Ther; 2005 Jul; 27(7):993-1003. PubMed ID: 16154478
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain.
Southworth S; Peters J; Rock A; Pavliv L
Clin Ther; 2009 Sep; 31(9):1922-35. PubMed ID: 19843482
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
18. [The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study].
Mateo D; Giménez-Roldán S
Neurologia; 1996 Jan; 11(1):16-9. PubMed ID: 8714171
[TBL] [Abstract][Full Text] [Related]
19. Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?
Güngör L; Terzi M; Onar MK
Brain Lang; 2011 Apr; 117(1):23-7. PubMed ID: 21227483
[TBL] [Abstract][Full Text] [Related]
20. Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot study.
Secades JJ; Alvarez-Sabín J; Rubio F; Lozano R; Dávalos A; Castillo J;
Cerebrovasc Dis; 2006; 21(5-6):380-5. PubMed ID: 16490951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
